Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 08, 2025, titled "Zydus receives final approval from USFDA for Glatiramer Acetate Injection, the generic version of Copaxone? 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes".